Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid .beta. for induction of an immune r Title: United States Patent: 7,427,655 Inventors: Frangione; Blas (New York, NY), Wisniewski; Thomas (Staten Island, NY), Sigurdsson; Einar M.(Scarsdale, NY) Assignee: New York University (New York, NY) Appl.
No.: 10/666,423 Filed:...
Screen rankings as of 06OCT08 3PT_Value_SmallCap NAFC SPTN SWX CASY GAS SXI AVA UIL LG NPK HE THS MGEE SJI ALE WST PNY LNCE STE APSG MANT SWWC CPSI CHTT HAE 3PT_SCV_pst SWX WGL CASY SXI GAS UIL AVA LG NPK CAI HE SJI MGEE ALE WST PNY LNCE STE SWWC IART HAE 3PT_SCV_pst...
Thigh Pain After Total Hip Replacement: A Pathophysiological Review and a Comprehensive Classification Describe the clinical and radiological features of thigh pain related to femoral total hip components.Discuss the pathophysiology of thigh pain in total hip replacement (THR) patients.
Describe the classification system for thigh pain...
Vaccine composition of surfactants as adjuvant of immunity Title: United States Patent: 7,422,748 Inventors: Aucouturier; Jerome (Chatenay Malabry, FR), Ganne; Vincent (La Varenne Saint Hilaire, FR), Trouve; Gerard (Castres, FR) Assignee: Societe d'Exploitation de Produits pour les Industries...
Screen rankings as of 22SEP08 3PT_Value_SmallCap NAFC XRM ATO CNW SWX CASY LPNT LII FOE CTS IVC JAS SXI SLGN GAS UNS RKT WGL TG UIL ROCK AHS AVA FL OMI 3PT_SCV_pst ATO SWX CNW LPNT LII CASY IVC SXI RBC AOS SLGN WGL UNS UIL GAS AHS AVA RKT OMI LG PZZA KWR PII CHG FSS 3PT...
Screen rankings as of 15SEP08 3PT_Value_SmallCap NAFC ATO XRM SWX UGI BJ NNBR LPNT CASY SLGN LII FOE SHLM GAS IVC WGL CEC JAS CTS RKT FINL UNS LG SXI NWY 3PT_SCV_pst ATO SWX BJ LPNT AOS LII SLGN WGL SHLM IVC CASY GAS RBC BMS MLHR RKT UNS LG AVA KWR SXI AHS PZZA FSS UNF...
Screen rankings as of 08SEP08 ACCDIS CRY THOR BWLD URBN IT ASGN HLEX ENER AXYS BKE ARO WAB VAR ROST WRC STE WGOV PMCS BIG ZOLL CCC TTEK STRA ECOL SYNA AD THOR ASGN IT BWLD URBN AXYS PMCS ZOLL BIG FCN TTEK ARO SYNA WRC ROST STRA WGOV ECOL PNRA BKE WAB STE VAR WMT AssRS13...
Indevus completes enrollment for Phase III study of HIV drug MDP 301 is a multi-national, randomized, double-blind, placebo-controlled Phase III trial designed to examine the safety and effectiveness of PRO 2000 in preventing HIV infection in women.The trial will also assess effects on other...
Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 LEXINGTON, Mass., Aug.22 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc.
(Nasdaq: IDEV - News) announced today the completion of enrollment in Protocol MDP 301, a Phase III clinical trial of PRO 2000, the Company's...
Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 Women Enrolled in Trial Sponsored by Medical Research Council LEXINGTON, Mass., August 22, 2008 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc.announced today the completion of enrollment in Protocol MDP 301, a Phase III...
